Medicine Description empacoza 10mg
empacoza 10mg tablets is a medication that operates primarily as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. By inhibiting SGLT2 in the proximal tubules of the kidney, empagliflozin effectively reduces glucose reabsorption back into the bloodstream, promoting the excretion of excess glucose through urine. This mechanism not only helps lower blood sugar levels in patients with type II diabetes but also contributes to weight loss and a reduction in blood pressure. Additionally, empagliflozin has been shown to provide cardiovascular protection and support kidney function, making it an essential option for managing overall health in diabetic patients.
Indications and Uses of empacoza 10mg tablets
- Management of type II diabetes mellitus as an adjunct to diet and exercise.
- Reduction of cardiovascular risk in adults with type II diabetes and established cardiovascular disease.
- Support in the treatment of chronic kidney disease in patients with type II diabetes.
Side Effects of empacoza 10mg tablets
- Urinary tract infections
- Genital mycotic infections
- Increased urination
- Dehydration and hypotension
- Hypoglycemia when used with other antidiabetic medications
- Potential risk of ketoacidosis
Storage and Handling
Store empacoza 10mg tablets at room temperature, away from moisture and heat, ideally in a tightly sealed container. Keep out of reach of children.
Patient Advice and Precautions
Patients should be advised to maintain adequate hydration, monitor blood sugar levels regularly, and be aware of signs of urinary tract infections or genital infections. It is also crucial to inform healthcare providers about any simultaneous medications or pre-existing health conditions to mitigate potential interactions or side effects.